Related Experiment Video
Updated: May 27, 2025

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
MnO2-Assisted Photosynthetic Bacteria Interfering with the Adenosine-A2AR Metabolic Pathway to Enhance Tumor
Si-Min Zeng1, Wen-Qiang Qu1, Yu-Liang Sun1
1Department of Orthopedic Trauma and Microsurgery of Zhongnan Hospital & Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, PR China.
Abstract:
Hypoxia-related adenosine (Ado) exerts an immunosuppressive effect in tumors by binding to the metabolic checkpoint Ado A2A receptors (A2AR), thereby hindering the activation of antitumor immunity induced by immunogenic cell death (ICD). In this study, a MnO2-assisted photosynthetic bacteria (PSB) biohybrid (MnO2@PSB) is developed to enhance tumor photothermal immunotherapy by interfering with the Ado-A2AR metabolic pathway. Specifically, manganese dioxide (MnO2) nanoflowers are conjugated onto PSB by the carbodiimide reaction to construct the biohybrid MnO2@PSB. As a photothermal agent, MnO2@PSB generates heat to "burn" tumor cells under 808 nm laser irradiation, inducing tumor cell ICD. Meanwhile, MnO2@PSB catalyzes the decomposition of endogenous hydrogen peroxide into oxygen to alleviate tumor hypoxia, thereby reducing Ado production and downregulating the expression of A2AR, further reversing the tumor immunosuppressive microenvironment and amplifying the ICD effects. In various mouse 4T1 tumor models, MnO2@PSB can enhance antitumor immune responses, prolong mouse survival, and significantly inhibit tumor growth, recurrence, and metastasis under 808 nm laser irradiation. Collectively, this study provides a direction for enhanced antitumor immunotherapy through regulating metabolic pathways.
Insights
This study developed a manganese dioxide-assisted photosynthetic bacteria biohybrid (MnO2@PSB) to enhance cancer immunotherapy. MnO2@PSB reverses tumor immunosuppression and amplifies anti-tumor immune responses.
Area of Science:
- Biomedical Engineering
- Immunology
- Materials Science
Background:
- Tumor hypoxia promotes immunosuppression via adenosine (Ado) and A2A receptors (A2AR).
- Adenosine A2A receptor (A2AR) signaling hinders anti-tumor immunity, particularly following immunogenic cell death (ICD).
Purpose of the Study:
- To develop a MnO2-assisted photosynthetic bacteria (PSB) biohybrid (MnO2@PSB) for enhanced photothermal immunotherapy.
- To investigate the interference of MnO2@PSB with the adenosine-A2AR metabolic pathway in tumors.
Main Methods:
- Conjugation of manganese dioxide (MnO2) nanoflowers onto photosynthetic bacteria (PSB) via carbodiimide reaction.
- Utilizing MnO2@PSB as a photothermal agent under 808 nm laser irradiation to induce tumor cell ICD.
- Leveraging MnO2 to catalyze hydrogen peroxide decomposition, alleviating tumor hypoxia and reducing adenosine production.
Main Results:
- MnO2@PSB treatment induced tumor cell immunogenic cell death (ICD).
- Alleviation of tumor hypoxia reduced adenosine production and A2AR expression, reversing the immunosuppressive microenvironment.
- Enhanced anti-tumor immune responses, prolonged survival, and inhibited tumor growth, recurrence, and metastasis in mouse models.
Conclusions:
- The MnO2@PSB biohybrid effectively enhances photothermal immunotherapy by targeting the adenosine-A2AR metabolic pathway.
- This approach offers a promising strategy for overcoming tumor immunosuppression and improving therapeutic outcomes.
- Regulating metabolic pathways presents a viable direction for advancing anti-tumor immunotherapy.
More Related Videos
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...